keyword
https://read.qxmd.com/read/38684142/cryoprobe-for-endoscopic-enucleation-in-children-with-pulmonary-tuberculosis-effective-but-not-without-danger-case-report-and-review-of-literature
#21
Pierre Goussard, Ernst Eber, Shyam Sunder B Venkatakrishna, Jacques Janson, Pawel Tomasz Schubert, Lars Ebert, Janette Verster, Marthinus Basson, Andre Gie, Savvas Andronikou
INTRODUCTION: Tuberculosis (TB) in children under 15 years often results in airway compression, with bronchus intermedius (BI) being the most common site. Endoscopic enucleations can be used to remove lymph nodes and establish an airway in severe cases. Both rigid and flexible bronchoscopy are suitable, with alligator forceps being preferred for its ability to extract tissue. Recent studies have also explored cryoprobe enucleation. CASE PRESENTATION: An HIV-positive boy with persistent symptoms after 9 months of TB treatment was diagnosed based on his mother's and sister's Xpert MTB/RIF positive status...
April 29, 2024: Respiration; International Review of Thoracic Diseases
https://read.qxmd.com/read/38681434/rare-case-of-lower-gastrointestinal-bleeding-secondary-to-miliary-tuberculosis-in-the-united-states
#22
Marta B Sekh, Alexa B Jack, Danielle A Rowe, Nitori G Henderson, Michael R Zemaitis
Tuberculosis (TB) remains a significant global health challenge. Miliary TB is a rare manifestation of TB that involves systemic lymphohematogenous dissemination of infection and presents diagnostic challenges due to its often asymptomatic or non-specific nature. This case report documents a rare occurrence of gastrointestinal (GI) bleeding secondary to miliary TB without pulmonary symptoms in an 81-year-old Filipino-American male living in the United States. Extensive imaging studies revealed a mass in the right colon with multiple bleeding vessels draped around it; it was not amendable to treatment with embolization and required right hemicolectomy with end ileostomy...
March 2024: Curēus
https://read.qxmd.com/read/38680787/latent-tb-treatment-regimens-in-2023-wetmore-tb-clinic-in-new-orleans
#23
JOURNAL ARTICLE
Amy Wolfe, Priyanka Jadhav, Amber May, Shandrica Seymour, Angela Blanchard, Juzar Ali
The USPSTF has updated Latent TB Infection (LTBI) screening and treatment recommendations in 2023; describing treatment courses, side effects and benefits associated with each regimen. Overall, rifampin-containing shortened regimens are the preferred modality for LTBI treatment. A recent study in 2023 evaluated adherence and tolerance of the isoniazid(INH) + rifapentine(RPT), or "3HP" regimen and identified patient groups that may be at higher risk for non-completion of this regimen. It emphasized the need for targeted education at the beginning of treatment, to avoid early discontinuation...
May 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38680271/thoracic-spine-infection-caused-by-pseudomonas-fluorescens-a-case-report-and-review-of-literature
#24
Liang Li, Bao-Hua Zhang, Jin-Feng Cao, Li-Jin Zhang, Ling-Ling Guo
BACKGROUND: The clinical incidence of spinal infection is gradually increasing, and its onset is insidious, easily leading to missed diagnosis and misdiagnosis, which may lead to serious complications such as nervous system dysfunction, spinal instability and/or deformity, and cause a huge burden on society and families. Early identification of the causative agent and precision medicine will greatly reduce the suffering of patients. At present, the main pathogenic bacteria that cause spinal infection are Staphylococcus aureus , Streptococcus, Pneumococcus, Escherichia coli , and Klebsiella...
April 26, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38676952/actionable-mechanisms-of-drug-tolerance-and-resistance-in-mycobacterium-tuberculosis
#25
REVIEW
Dipanwita Datta, Shaina Jamwal, Nishant Jyoti, Srinivas Patnaik, Dhiraj Kumar
The emergence of antimicrobial resistance (AMR) across bacterial pathogens presents a serious threat to global health. This threat is further exacerbated in tuberculosis (TB), mainly due to a protracted treatment regimen involving a combination of drugs. A diversity of factors contributes to the emergence of drug resistance in TB, which is caused by the pathogen Mycobacterium tuberculosis (Mtb). While the traditional genetic mutation-driven drug resistance mechanisms operate in Mtb, there are also several additional unique features of drug resistance in this pathogen...
April 27, 2024: FEBS Journal
https://read.qxmd.com/read/38676596/results-of-omalizumab-treatment-in-chronic-eosinophilic-pneumonia-real-life-data
#26
JOURNAL ARTICLE
Buket Başa Akdoğan, Kurtuluş Aksu, İlkay Koca Kalkan, Gözde Köycü Buhari, Özlem Özdedeoğlu, Hale Ateş, Ferda Öner Erkekol
INTRODUCTION: Recurrences occur when corticosteroid therapy is discontinued or reduced during the treatment of chronic eosinophilic pneumonia (CEP). The probability of recurrence is once in 50% of patients and twice or more in 25%. In such instances, new treatment options are deemed necessary. This study aims to assess the efficacy of omalizumab treatment as a steroid-sparing drug in patients with CEP. MATERIALS AND METHODS: The clinical features of patients treated with omalizumab for recurrent CEP were evaluated retrospectively before and after treatment...
March 2024: Tüberküloz Ve Toraks
https://read.qxmd.com/read/38676494/a-review-of-the-association-between-infections-seizures-and-drugs
#27
JOURNAL ARTICLE
Zahra Tolou-Ghamari
BACKGROUND: Seizures are a common presenting symptom of the central nervous system (CNS) and could occur from infections (such as toxins) or drugs. OBJECTIVE: The aim of this study was to present a systematic review of the association between infections, seizures, and drugs. METHODS: Through February 18, 2024, according to the PRISMA guidelines and based on the PICO standard format, relevant, in-depth consequent guide approach and evidence-based options were selected associated with a knowledgeable collection of current, high-quality manuscripts...
April 25, 2024: Central Nervous System Agents in Medicinal Chemistry
https://read.qxmd.com/read/38675885/mechanisms-and-cardiorenal-complications-of-chronic-anemia-in-people-with-hiv
#28
REVIEW
Kingsley Kamvuma, Benson M Hamooya, Sody Munsaka, Sepiso K Masenga, Annet Kirabo
Chronic anemia is more prevalent in people living with HIV (PLWH) compared to the general population. The mechanisms that drive chronic anemia in HIV are multifaceted and include functional impairment of hematopoietic stem cells, dysregulation of erythropoietin production, and persistent immune activation. Chronic inflammation from HIV infection adversely affects erythropoiesis, erythrocyte lifespan, and erythropoietin response, leading to a heightened risk of co-infections such as tuberculosis, persistent severe anemia, and increased mortality...
March 30, 2024: Viruses
https://read.qxmd.com/read/38675837/advances-in-antiretroviral-therapy-for-patients-with-human-immunodeficiency-virus-associated-tuberculosis
#29
REVIEW
Xiaoqin Le, Yinzhong Shen
Tuberculosis is one of the most common opportunistic infections and a prominent cause of death in patients with human immunodeficiency virus (HIV) infection, in spite of near-universal access to antiretroviral therapy (ART) and tuberculosis preventive therapy. For patients with active tuberculosis but not yet receiving ART, starting ART after anti-tuberculosis treatment can complicate clinical management due to drug toxicities, drug-drug interactions and immune reconstitution inflammatory syndrome (IRIS) events...
March 23, 2024: Viruses
https://read.qxmd.com/read/38673641/infectious-diseases-and-basal-ganglia-calcifications-a-cross-sectional-study-in-patients-with-fahr-s-disease-and-systematic-review
#30
REVIEW
Birgitta M G Snijders, Mike J L Peters, Susanne van den Brink, Marijke J C A van Trijp, Pim A de Jong, Laurens A T M Vissers, Frans M Verduyn Lunel, Marielle H Emmelot-Vonk, Huiberdina L Koek
Background: It is unclear whether patients with basal ganglia calcifications (BGC) should undergo infectious disease testing as part of their diagnostic work-up. We investigated the occurrence of possibly associated infections in patients with BGC diagnosed with Fahr's disease or syndrome and consecutively performed a systematic review of published infectious diseases associated with BGC. Methods: In a cross-sectional study, we evaluated infections in non-immunocompromised patients aged ≥ 18 years with BGC in the Netherlands, who were diagnosed with Fahr's disease or syndrome after an extensive multidisciplinary diagnostic work-up...
April 18, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38672487/htpg-a-major-virulence-factor-and-a-promising-vaccine-antigen-against-mycobacterium-tuberculosis
#31
REVIEW
Rita Berisio, Giovanni Barra, Valeria Napolitano, Mario Privitera, Maria Romano, Flavia Squeglia, Alessia Ruggiero
Tuberculosis (TB) is the leading global cause of death f rom an infectious bacterial agent. Therefore, limiting its epidemic spread is a pressing global health priority. The chaperone-like protein HtpG of M. tuberculosis (Mtb) is a large dimeric and multi-domain protein with a key role in Mtb pathogenesis and promising antigenic properties. This dual role, likely associated with the ability of Heat Shock proteins to act both intra- and extra-cellularly, makes HtpG highly exploitable both for drug and vaccine development...
April 11, 2024: Biomolecules
https://read.qxmd.com/read/38670270/understanding-the-potential-role-of-whole-genome-sequencing-wgs-in-managing-patients-with-gonorrhoea-a-systematic-review-of-wgs-use-on-human-pathogens-in-individual-patient-care
#32
JOURNAL ARTICLE
Roeann Osman, Emily Dema, Alexandra David, Gwenda Hughes, Nigel Field, Michelle Cole, Xavier Didelot, John Saunders
OBJECTIVES: The utility of whole genome sequencing (WGS) to inform sexually transmitted infection (STI) patient management is unclear. Timely WGS data might support clinical management of STIs by characterising epidemiological links and antimicrobial resistance profiles. We conducted a systematic review of clinical application of WGS to any human pathogen that may be transposable to gonorrhoea. METHODS: We searched six databases for articles published between 01/01/2010-06/02/2023 that reported on real/near real-time human pathogen WGS to inform clinical intervention...
April 24, 2024: Journal of Infection
https://read.qxmd.com/read/38670256/recent-advances-in-the-development-of-dpre1-inhibitors-using-ai-cadd-approaches
#33
REVIEW
Kepeng Chen, Ruolan Xu, Xueping Hu, Dan Li, Tingjun Hou, Yu Kang
Tuberculosis (TB) is a global lethal disease caused by Mycobacterium tuberculosis (Mtb). The flavoenzyme decaprenylphosphoryl-β-d-ribose 2'-oxidase (DprE1) plays a crucial part in the biosynthesis of lipoarabinomannan and arabinogalactan for the cell wall of Mtb and represents a promising target for anti-TB drug development. Therefore, there is an urgent need to discover DprE1 inhibitors with novel scaffolds, improved bioactivity and high drug-likeness. Recent studies have shown that artificial intelligence/computer-aided drug design (AI/CADD) techniques are powerful tools in the discovery of novel DprE1 inhibitors...
April 24, 2024: Drug Discovery Today
https://read.qxmd.com/read/38669897/leishmania-vaccine-development-a-comprehensive-review
#34
REVIEW
Isha Saini, Jyoti Joshi, Sukhbir Kaur
Infectious diseases like leishmaniasis, malaria, HIV, tuberculosis, leprosy and filariasis are responsible for an immense burden on public health systems. Among these, leishmaniasis is under the category I diseases as it is selected by WHO (World Health Organization) on the ground of diversity and complexity. High cost, resistance and toxic effects of Leishmania traditional drugs entail identification and development of therapeutic alternative. Since the natural infection elicits robust immunity, consistence efforts are going on to develop a successful vaccine...
April 23, 2024: Cellular Immunology
https://read.qxmd.com/read/38669225/catastrophic-costs-for-tuberculosis-patients-in-india-impact-of-methodological-choices
#35
JOURNAL ARTICLE
Susmita Chatterjee, Palash Das, Guy Stallworthy, Gayatri Bhambure, Radha Munje, Anna Vassall
As financial risk protection is one of the goals towards universal health coverage, detailed information on costs, catastrophic costs and other economic consequences related to any disease are required for designing social protection measures. End Tuberculosis (TB) Strategy set a milestone of achieving zero catastrophic cost by 2020. However, a recent literature review noted that 7%-32% TB affected households in India faced catastrophic cost. Studies included in the review were small scale cross-sectional. We followed a cohort of 1482 notified drug-susceptible TB patients from four states in India: Assam, Maharashtra, Tamil Nadu, and West Bengal to provide a comprehensive picture of economic burden associated with TB treatment...
2024: PLOS Glob Public Health
https://read.qxmd.com/read/38669118/research-progress-on-liposome-pulmonary-delivery-of-mycobacterium-tuberculosis-nucleic-acid-vaccine-and-its-mechanism-of-action
#36
REVIEW
Danyang Zhang, Haimei Zhao, Ping Li, Xueqiong Wu, Yan Liang
Traditional vaccines have played an important role in the prevention and treatment of infectious diseases, but they still have problems such as low immunogenicity, poor stability, and difficulty in inducing lasting immune responses. In recent years, the nucleic acid vaccine has emerged as a relatively cheap and safe new vaccine. Compared with traditional vaccines, nucleic acid vaccine has some unique advantages, such as easy production and storage, scalability, and consistency between batches. However, the direct administration of naked nucleic acid vaccine is not ideal, and safer and more effective vaccine delivery systems are needed...
April 26, 2024: Journal of Aerosol Medicine and Pulmonary Drug Delivery
https://read.qxmd.com/read/38667755/narrative-review-explaining-the-role-of-hla-a-b-and-c-molecules-in-covid-19-disease-in-and-around-africa
#37
REVIEW
Lisa Naidoo, Thilona Arumugam, Veron Ramsuran
The coronavirus disease 2019 (COVID-19) has left a devasting effect on various regions globally. Africa has exceptionally high rates of other infectious diseases, such as tuberculosis (TB), human immunodeficiency virus (HIV), and malaria, and was not impacted by COVID-19 to the extent of other continents Globally, COVID-19 has caused approximately 7 million deaths and 700 million infections thus far. COVID-19 disease severity and susceptibility vary among individuals and populations, which could be attributed to various factors, including the viral strain, host genetics, environment, lifespan, and co-existing conditions...
April 18, 2024: Infectious Disease Reports
https://read.qxmd.com/read/38665915/the-causes-and-consequences-of-trained-immunity-in-myeloid-cells
#38
REVIEW
Gunapati Bhargavi, Selvakumar Subbian
Conventionally, immunity in humans has been classified as innate and adaptive, with the concept that only the latter type has an immunological memory/recall response against specific antigens or pathogens. Recently, a new concept of trained immunity (a.k.a. innate memory response) has emerged. According to this concept, innate immune cells can exhibit enhanced responsiveness to subsequent challenges, after initial stimulation with antigen/pathogen. Thus, trained immunity enables the innate immune cells to respond robustly and non-specifically through exposure or re-exposure to antigens/infections or vaccines, providing enhanced resistance to unrelated pathogens or reduced infection severity...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38664351/bacillus-calmette-gu%C3%A3-rin-bcg-induced-protection-in-brain-disorders
#39
REVIEW
Khiany Mathias, Richard Simon Machado, Solange Stork, Carla Damasio Martins, Amanda Christine da Silva Kursancew, Victória Linden de Rezende, Cinara Ludvig Gonçalves, Tatiana Barichello, Josiane Somariva Prophiro, Fabricia Petronilho
The Bacille Calmette-Guerin (BCG) vaccine is one of the most widely used vaccines in the world for the prevention of tuberculosis. Its immunological capacity also includes epigenetic reprogramming, activation of T cells and inflammatory responses. Although the main usage of the vaccine is the prevention of tuberculosis, different works have shown that the effect of BCG can go beyond the peripheral immune response and be linked to the central nervous system by modulating the immune system at the level of the brain...
April 26, 2024: Inflammation
https://read.qxmd.com/read/38663653/-re-introduction-of-tnf-antagonists-and-jak-inhibitors-in-patients-with-previous-tuberculosis-a-systematic-review
#40
REVIEW
Thomas Theo Rehm, Maja Reimann, Niklas Köhler, Christoph Lange
BACKGROUND: Tuberculosis (TB) is a common complication associated with treatment with tumor necrosis factor (TNF) antagonists and Janus kinase (JAK) inhibitors. However, there is uncertainty about the risk of TB relapse in patients with TB and comorbidities requiring treatment with these agents. OBJECTIVES: Partner Site Hamburg-Lübeck-Borstel-Riems. To assess the risk of TB relapse in patients (re-)started on TNF antagonists or JAK inhibitors. METHODS: Systematic review...
April 23, 2024: Clinical Microbiology and Infection
keyword
keyword
25687
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.